retatrutide ada 2025 results New Phase 3 data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving historically associated with bariatric surgery. A few important caveats Experts to reveal results of

Quick Answer Retatrutide has a half-life of approximately 6 days , according to the Phase 2 clinical trial published in the New England Journal of Medicine (Jastreboff et al., 2023)

It protects heart health, lowers inflammation, and reduces the risk of chronic diseases such as diabetes and certain cancers

Eggs, Greek yogurt, or a protein shake are popular choices

Certain formulations are FDA-approved to lower the risk of serious cardiovascular events, such as heart attacks and strokes, in adults with heart disease who are overweight or obese

Stick to framing your research as educational and focused on making an informed medical decision

Ann Pharmacother (2017) 51:4019